Eton Pharmaceuticals Inc.
ETON | NASDAQ
$55.31
-$0.19 (-0.34%)
At close: Sep 21, 2026, 4:00 PM ET
$56
+$0.69 (+1.25%)
Pre-market:
Sep 22, 2026, 8:18 AM ET
Market Data
Market Cap $1.52B
Enterprise Value $1.5B
Beta 0.90
Average Volume 517.16K
Shares Outstanding (Diluted) 32.3M
Shares Change YoY 21.92%
Institutional Ownership 65.18%
Exchange NASDAQ
ISIN US29772L1089
Price Performance
Price Change 1M -13.6%
Price Change 3M 65.2%
Price Change 6M 132.0%
Price Change YTD 240.2%
Price Change 1Y 201.1%
Price Change 3Y 1092.0%
Price Change 5Y 1004.0%
1M CAGR (ann.) 24.0%
1Y CAGR (ann.) 199.6%
5Y CAGR (ann.) 61.3%
All-Time CAGR 32.0%
Valuation
PE Ratio 145.55
Forward PE 26.88
PEG Ratio 0.16
Forward PEG 1.28
PS Ratio 14.35
Forward PS 6.90
PB Ratio 32.52
P/FCF Ratio 102.84
P/Adj. FCF Ratio 158.98
P/OCF Ratio 100.56
EV/Sales 14.19
EV/EBIT 573.34
EV/EBITDA 98.04
EV/FCF 101.69
Earnings Yield 0.7%
FCF Yield 1.0%
Adj. FCF Yield 0.6%
Financial Health
Net Cash $16.94M
Total Debt $9.91M
Cash & Short-Term Investments $26.85M
Total Assets $115.81M
Current Ratio 1.52
Quick Ratio 1.30
Debt / Equity Ratio 0.62
Debt / EBITDA 0.65
Debt / FCF 0.67
OCF / Debt 1.53
Interest Coverage 6.14
Altman Z-Score 13.16
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 57.9%
Operating Profit Margin 15.4%
EBITDA Margin 17.6%
Net Profit Margin 12.0%
FCF Margin 13.9%
Adj. FCF Margin 9.0%
SBC / Revenue 4.9%
SBC Impact (per share) -35.3%
Returns
Return on Assets 11.0%
Return on Equity 40.1%
Return on Invested Capital 20.4%
Return on Capital Employed 23.1%
Return on Tangible Assets 18.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 53.8%
Revenue CAGR 5Y 48.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 3200.0%
EPS CAGR 5Y 150.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y 46.6%
FCF CAGR 5Y 130.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 119.0%
Revenue Growth Next 3Y 58.9%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.34
EPS Growth Est (next Q) -585.7%
Revenue Est (next Q) $41.98M
Revenue Growth Est (next Q) 86.9%
Fair Value Estimates
Graham Number $3.80
Graham Upside -93.1%
Lynch Fair Value $9.50
Lynch Upside -82.8%
Price Target $66.67
Price Target Upside 20.5%
Cash Flow
Operating Cash Flow $15.14M
Free Cash Flow $14.73M
Adj. Free Cash Flow $9.53M
FCF Per Share $0.53
OCF Per Share $0.55
OCF/S Ratio 14.3%
Income Statement
Revenue $105.6M
Gross Profit $61.1M
Operating Income $16.31M
EBITDA $15.28M
Net Income $12.69M
EPS (Diluted) $0.38
Revenue / Employee $2.4M
Profit / Employee $288.36K
Employees 44
Add to Watchlist
Select watchlists to add or remove ETON